Anthem Biosciences, a Bengaluru-based biopharma company, is set to open its Rs 3,395-crore IPO from July 14 to July 16.

Despite broader regional challenges, Malaysia leads Southeast Asia's initial public offering (IPO) performance in the first half, Deloitte data showed.

Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—are set to launch IPOs aiming to raise over Rs 3,600 crore amid ...

In a filing Friday with the SEC, the space and defense technology firm that landed on the moon in March laid out plans for ...

Firefly Aerospace has filed for an initial public offering on the Nasdaq under the ticker ‘FLY,’ aiming to turn its recent ...

NLC India Ltd will invest ₹1.25 lakh crore by 2030, focusing heavily on renewable energy including solar, wind, pumped hydro, ...

Think you know everything about cryptocurrencies? Find out why stablecoins are getting so much attention in the investing ...

Anthem Biosciences IPO: The Bengaluru-based company, Anthem Biosciences, has secured Rs 1,016 crore from anchor investors ...

IPO Papers, Draft IPO Papers: A total of five companies including Orient Cables and ICICI Prudential, among others, filed ...

As per the circular, the company has allocated 1.78 crore equity shares to 60 funds at Rs 570 apiece, which is the upper end ...